Similarly, we further observed a significant increase in the histone acetylation level of OPTN promoter in metformin‐treated ocular melanoma cells through the chromatin immunoprecipitation (ChIP) assay (Figure 6B). The gene discussed is OPTN; the disease is ocular melanoma.